GlassScriptPhysician profile
Rishad Sultan Ahmed
NPI 1578918470
$11,736.61
in general payments reported to CMS, 2019-2025
21 companies · $425 in 2025
The $425 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,205 · 2020: $101 · 2021: $4,145 · 2022: $1,588 · 2023: $135 · 2024: $1,139 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,699.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Edge Orthopaedics, INC. | $3,663.79 | 2021-2024 | |
| Stryker Corporation | $1,809.15 | 2019-2024 | Infinity Adaptis |
| Arthrex, INC. | $1,520.00 | 2021 | |
| Orthofix Medical, INC. | $1,370.90 | 2019 | |
| Osteomed LLC | $953.37 | 2019 | |
| Smith+Nephew, INC. | $633.70 | 2021-2025 | Grafix Pl, Stravix Pl, Oasis Micro |
| Kerecis Limited | $547.72 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Integra Lifesciences Corporation | $279.24 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Depuy Synthes Sales INC. | $142.95 | 2020-2024 | Motoband |
| Pacira Pharmaceuticals Incorporated | $137.41 | 2019 | |
| Organogenesis INC. | $137.25 | 2022-2024 | Affinity |
| Biotissue Holdings INC. | $135.67 | 2022-2023 | |
| Solventum Corporation | $84.99 | 2024 | Prevena Restor Axioform, V.A.C. Veraflo Cleanse Choice |
| Abbott Laboratories | $64.12 | 2021-2025 | Gallant |
| Djo, LLC | $52.10 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $49.89 | 2021 | |
| Kci USA, INC. | $41.39 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $37.60 | 2023 | Seglentis |
| Reprise Biomedical, INC. | $37.50 | 2023 | Miro3d |
| Paratek Pharmaceuticals, INC. | $19.65 | 2022 | |
| Acera Surgical, INC. | $18.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rishad Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.